The National Institute for Innovation in Manufacturing Biopharmaceuticals ( NIIMBL ) announces the selection of 100 first- and second-year college students to participate in the 2025 NIIMBL experience program. Students were selected from 75 academic institutions across the United States and Puerto Rico to take part in one of seven NIIMBL eXperience...
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce student applications for the 2025 NIIMBL eXperience are now open. Students can apply to one of seven unique programs hosted by NIIMBL members across the country:
Albany College of Pharmacy and Health Sciences (ACPHS) (New York)...
he National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has contributed biopharmaceutical manufacturing ontologies to The Open Applications Group (OAGi) for further development as an open-source project. Shifting NIIMBLs ontology work to an open-source process will encourage broader involvement and adoption of common...
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has published in Biotechnology and Bioengineering . The paper serves as an update to a 2012 review titled authored by NIIMBL Executive Director Barry Buckland and explores...
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) officially launches the Viral Vectors NIIMBL-led Program focused on developing and making broadly available robust, economically viable, shared manufacturing process and analytical platforms for Adeno-Associated Virus (AAV) gene therapy vectors. NIIMBL has committed...
